Citi Starts Bellicum Pharmaceuticals (BLCM) at Buy
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Price: $0.62 --0%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Citi initiated coverage on Bellicum Pharmaceuticals (NASDAQ: BLCM) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Bellicum Pharmaceuticals click here. For more ratings news on Bellicum Pharmaceuticals click here.
Shares of Bellicum Pharmaceuticals closed at $18.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- D. Boral Capital Starts Eve Holding Inc. (EVEX) at Buy
- H.C. Wainwright Starts ImageneBio (IMA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
